Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
Date:5/4/2012

MOUNTAIN VIEW, Calif., May 4, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the first quarter ended March 31, 2012.

The net loss for the first quarter ended March 31, 2012 was $17.8 million, compared to a net loss of $16.0 million during the same period in 2011. The net loss for the first quarter ended March 31, 2012 included a one-time expense of $2.8 million for the purchase of a data package relating to the propellant used for LEVADEX. MAP Pharmaceuticals had $79.0 million in cash and cash equivalents as of March 31, 2012, compared to $98.8 million as of December 31, 2011.

"Following receipt of the Complete Response letter from the FDA on March 26 for our LEVADEX NDA submission, we will meet with the FDA in the second quarter of this year and we look forward to gaining clarity around the issues raised in the letter," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "We believe that LEVADEX has the potential to be an important treatment for many of the 30 million Americans who suffer from migraine, and we will continue to closely collaborate with the FDA to address the issues raised in the Complete Response letter as quickly as possible."

Revenues for the first quarter ended March 31, 2012 were $1.0 million, compared to $0.6 million for the same period in 2011. The revenues for both periods were due to amortization of a $60.0 million nonrefundable upfront cash payment received in February 2011, pursuant to a collaboration agreement with Allergan, Inc. entered into in January 2011.

Research and development (R&D) expenses for the first quarter ended March 31, 2012 were $11.0 million, compared to $11.6 million for the same period in 2011. The decrease in R&D expenses for the three months ended March 31, 2012 was caused primarily by a decrease in expen
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
2. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
3. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
5. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
8. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
9. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
10. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
11. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... y LONDRES, 28 de agosto de ... PHIA) anunció hoy su participación en el  Congreso ... sus soluciones cardiológicas más recientes y novedosas, entre ... que conectan a las personas y la tecnología ... ayudar a diagnosticar, guiar los tratamientos y permitir ...
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
(Date:8/27/2015)... According to a new market research report "Medical Lifting ... ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End User ... Medical Lifting Sling Market is poised to reach USD 706.0 Million ... of 11.4 % from 2015 to 2020. , ... ables and 65 F igures ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Demonstrates Significant Reduction in Incidence of GI Ulcers and ... Logical Therapeutics, Inc., a Waltham, MA-based biopharmaceutical company announced ... trial evaluating the gastrointestinal (GI) safety of its investigational ... bio-activated prodrugs being developed for the chronic treatment of ...
... , HOUSTON, Oct. 27 Bellicum Pharmaceuticals, Inc. today announced ... new funds will be used to complete the company,s ongoing ... independent prostate cancer, and to prepare for Phase IIb trials. ... trial in mid 2010. , The new funding brings the ...
Cached Medicine Technology:Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study 2Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study 3Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study 4Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
(Date:8/30/2015)... ... ... Certified Nutrition Businessman Reid Eckert agrees to extend his business relationship with ... sales and communications firm that offers U.S. brands a proven path to world markets. ... Reid Eckert, as his interpretation of the nutritional needs of the human body is ...
(Date:8/29/2015)... ... , ... On September 30, 2015, the Career and Transfer Center (CTC) at ... Maricopa Community Colleges , will be hosting a Job Expo to provide a professional, ... , The Expo has expanded to much more than just a typical job and ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... obstructive pulmonary disease (including emphysema), or asthma, are at higher risk from wildfire ... heart attack, heart failure or heart-rhythm problems (arrhythmia or irregular heartbeat) are also ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
Breaking Medicine News(10 mins):Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... ... it Happen, Making it Work! keynote speakers will both inspire and challenge participants with ... recreation. The 3rd biennial conference for public works, parks and recreation, designers, engineers and ... ...
... of high-risk couples could be viable, researchers say , FRIDAY, ... couples genetically to determine if they,re at risk of having ... , There is ongoing controversy about whether screening for SMA ... should be routinely offered to couples. , In this study, ...
... stable longer , THURSDAY, Feb. 4 (HealthDay News) -- New ... diabetes could benefit by using an artificial pancreas device to ... sleep and help them control their disease. , The findings, ... Lancet , examined use of an artificial pancreas by people ...
... ... PM Is a Great New Alternative to Over-The-Counter Sleep Aids , ... Houston (PRWEB) February 5, 2010 -- Houston-based Aikon Wellness, ... product, Somniac PM ( www.SomniacPM.com ). In a pre-market test, this natural sleep aid ...
... ... meet the need for small-scale reference cards that communicate core Lean concepts in a visually ... (PRWEB) February ... a set of twelve illustrated cards that teach core Lean concepts with a light and ...
... ... H1N1 influenza epidemic by facilitating easy transfer of health results to the Centers for ... ... leading provider of healthcare diagnostic information technology and outreach solutions, announced that its ...
Cached Medicine News:Health News:Hard Green Truths - Keynotes Suggest New Value Propositions for River Park Leaders 2Health News:Screening for Spinal Muscular Atrophy Not Cost-Effective: Study 2Health News:Artificial Pancreas Helps Type 1 Diabetics During Sleep 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 3Health News:Lean Thinking Pocket Cards Teach Core Concepts -- and Inspire Action 2Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 2Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 3
... offers the most comprehensive family of ... for Cataract incision, Glaucoma filtration, and ... is achieved with minimal tissue trauma ... eraser styles are available in 18, ...
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
Medicine Products: